Viewing Study NCT02899195


Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-06-15 @ 8:02 AM
Study NCT ID: NCT02899195
Status: COMPLETED
Last Update Posted: 2023-07-05
First Post: 2016-09-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Sponsor: PrECOG, LLC.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mesothelioma View
None Pleural Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable Mesothelioma View
None Durvalumab View
None Anti-Programmed Death-Ligand 1 Antibody View